TYMS, SHMT2, GALT, RENBP, and AMDHD2 were among the metabolic genes that had an unfavorable expression in colon cancer, meaning that their high expression in patients treated with 5-FU was associated with poorer prognosis. The gene discussed is GALT; the disease is malignant colon neoplasm.